Abstract:
PROBLEM TO BE SOLVED: To provide a new solubilizer which has together excellent solubilizing characteristics, improved stability, excellent physiological adaptability and application easiness in the form of a liquid. SOLUTION: The use of terpene alcohols having 10 carbon atoms which have been ethoxylated with 3 to 10 moles of ethylene oxide as solubilizers for sparingly water-soluble or sparingly water-dispersible compounds is cosmetic or pharmaceutical preparations or in concentrates for foods, in amounts of at least 3% by weight based on the finished preparations, or based on the concentrates.
Abstract:
PROBLEM TO BE SOLVED: To provide a novel plasticizer having marked dissolving auxilialy action with respect to a hardly soluble drug and low hemolytic activity in parenteral administration and adapted to pharmacological use, cosmetic use and food industril use. SOLUTION: A polymerized aliphatic acid derivative and a polymerized aliphatic alcohol derivative obtained by condensing polymerized 12-110C aliphatic acid or 12-110C aliphatic alcohol with a hydrophilic compd. selected from the group consisting of polyalcohols, monosaccharides, alkylene glycol, polyalkylene glycol and aminated polyalkylene glycohl is used as a solubilizing agent.
Abstract:
PROBLEM TO BE SOLVED: To obtain a polymeric powder or polymeric granules comprising a water-insoluble polymer and a water-soluble polymer, suitable as a binder for production of solid pharmaceutical dosage forms and capable of rapidly releasing active substance(s). SOLUTION: This polymeric powder or granules as binder comprise(s) 10-95 wt.% of polyvinyl acetate, 5-90 wt.% of an N-vinylpyrrolidone-contg. polymer, 0-20 wt.% of another water-soluble or water-swellable substance and 0-20 wt.% of a water-insoluble pulverizing agent, and in some cases, other additive(s). The content of the binder in the other objective dosage form is 0.5-20 wt.%. This polymeric powder or granules has (have) remarkable binding action, and does not disintegrate the dose form and also does not virtually affect the release of the active substance(s) included in the preparation within the concentration range of 0.5-20 wt.%, based on the whole weight of the prescribed preparation as the dosage form.
Abstract:
PROBLEM TO BE SOLVED: To provide a method and a composition for carrying out a beauty culture treatment of the skin and/or the hair in order to improve the appearance of the skin. SOLUTION: A method for cosmetically treating the skin comprises coating the skin with a cosmetic composition comprising 5'-deoxy-5'-methylthioadenosine and/or its cosmetically acceptable salt in an effective amount for improving the appearance of the skin. COPYRIGHT: (C)2003,JPO
Abstract:
PROBLEM TO BE SOLVED: To provide an oral administration form exhibiting a delayed active substance release and a high mechanical stability, since the method for adjusting the above releasing profile while maintaining the skeletal and mechanical stability is not publicly known. SOLUTION: This oral administration form exhibiting the delayed active substance release and the high mechanical stability is provided by incorporating a) >=1 active substance, b) a blended mixture consisting of a polyvinyl acetate and polyvinylpyrrolidone, c) a water soluble polymer, or a low molecular weight or high molecular weight lipophilic additive and d) other usually used assistants.
Abstract:
PROBLEM TO BE SOLVED: To provide a new coating for masking the taste of oral pharmaceutical preparations, from which the defects of the prior arts are excluded. SOLUTION: This coating comprises (a) poly(vinyl acetate), (b) a hydrophilic additive, (c) other commonly used coating components and, when necessary, (d) an physiologically compatible acid.
Abstract:
PROBLEM TO BE SOLVED: To obtain a polymer dispersion having a low monomer content and excellent storage stability by adjusting the pH of a starting aqueous dispersion by adding at least two basic reagents thereto in a plurality of stages in the course of polymerizing a free-radical-polymerizable ethylenically unsaturated monomer in an aqueous system in the presence of a polymerization initiator. SOLUTION: At least one free-radical-polymerizable ethylenically unsaturated monomer is polymerized in the presence of an acidic polymerization initiator in an aqueous system whose pH has been adjusted at a constant value in the range of 1-7.5 by the addition of a reagent 1 being a salt of an acid selected from the group consisting of carbonic acid, boric acid, acetic acid, citric acid, and phosphoric acid. After the polymerization initiator is consumed, the polymerization is continued in the presence of a redox catalyst, and reagent 1 is further added to the aqueous dispersion to buffer it. The aqueous dispersion is adjusted to a pH of 6-10 by the addition of a reagent 2 being a base selected from the group consisting of an alkali (alkaline earth) metal hydroxide, ammonia, and a primary to tertiary amine to obtain an aqueous polymer dispersion having a residual monomer content of 100 ppm or below.
Abstract:
PROBLEM TO BE SOLVED: To obtain a solubilizing agent having a sufficient solubility and high solubilizing activities in water, and capable of being applied to medicines, cosmetics and foods. SOLUTION: This use is the one of copolymers comprising (a) 82-99.9 mol.% of at least one monoethylenically unsaturated a 3-8C carboxylic acid, (b) 0.1-18 mol.% of at least one monomer selected from the group of (b1 ) N-(8-30C alkyl)- substituted amides of monoethylenically unsaturated 3-8C carboxylic acids, (b2 ) N,N-(8-30C dialkyl)-substituted amides of monoethylenically unsaturated 3-8C carboxylic acids and (b3 ) 8-30C alkyl esters of monoethylenically unsaturated 3-8C carboxylic acids, and (c) 0-17.9 mol.% of at least one monomer selected from the group of (c1 ) vinyl esters of aliphatic 8-30C carboxylic acids and (c2 ) 8-30C alkylvinyl ethers, in which the mol.% data for the individual components adding up to 100%, as a solubilizer.
Abstract:
A film coating containing polyvinyl acetate and hydrophilic additives is used for masking the flavor of oral administration forms. The film coating consists of: (a) polyvinyl acetate (PVA); (b) hydrophilic additives; (c) usual coating components; and optionally (d) a physiologically compatible acid. Independent claims are also included for the following: (1) oral administration forms comprising a core containing active substance coated with the film coating; and (2) the production of medicament-containing oral administration forms using the film coating.
Abstract:
Sustained-release oral dosage form that floats in gastric fluid comprises: (1) one or more active ingredients; (2) a blend of polyvinyl acetate (PVAc) and polyvinylpyrrolidone (PVP); and optionally (3) excipients. An independent claim is also included for production of the dosage form by compression at a pressure below 100 MPa.